Bing‐Hua Jiang

机构：Qingdao University, Academy of Medical Sciences, Tiangong University, Utah Tech University, Lanzhou University of Technology, Chengdu University of Information Technology, Chengdu University of Technology, Zhengzhou University, Henan Academy of Sciences, Zhengzhou University of Science and Technology, Gansu University of Traditional Chinese Medicine, Chaohu Hospital of Anhui Medical University, Affiliated Hospital of Qingdao University, Chengdu University, Henan Cancer Hospital, Third Affiliated Hospital of Zhengzhou University · ORCID：0000-0003-4526-2031

发表论文 415 篇 · 总被引 40291 次 · h-index 89

代表论文

• SLC7A5/E2F1/PTBP1/PKM2 axis mediates progression and therapy effect of triple-negative breast cancer through the crosstalk of amino acid metabolism and glycolysis pathway (2025 · Cancer Letters · 被引 16)
• Anlotinib combined with benmelstobart as a chemo-free first-line treatment in advanced esophageal squamous cell carcinoma: an exploratory multicenter, single-arm phase II clinical trial (2025 · Molecular Cancer · 被引 10)
• Multiomics Integration of Epigenetics, Proteomics, and Metabolomics Identifies Putative Drug Targets and Improves Early Prediction for Diabetes (2025 · Diabetes · 被引 7)
• The Role of Gut Microbiota in the Association Between Air Pollution and Cognitive Function in Older Adults (2025 · Environmental Health Perspectives · 被引 7)
• Research Progress of Interfacial Modification of Copper/Diamond Composites for Electronic Packaging (2025 · International Journal of Thermophysics · 被引 6)
• Ultrafast synthesis of L-His-Fe3O4 nanozymes with enhanced peroxidase-like activity for effective antibacterial applications (2025 · Frontiers in Bioengineering and Biotechnology · 被引 6)